US tariffs on drugs ‘controllable’Staff writer, with CNAA task force of the Executive Yuan handling Taiwan-US trade yesterday said that the impact of new US tariffs on patented drugs is “controllable,” as Taiwan’s pharmaceutical exports to the US are generic. However, the order states that the tariff-free status of generic drugs would be reviewed within one year. The remaining 13.5 percent, or NT$1.32 billion in patented drugs, involve companies that have already planned US-based production, it added. “Overall, the impact on Taiwan’s pharmaceutical industry is controllable, and the government will continue to work closely with industry stakeholders to respond,” the task force said. The task force said it would continue to engage with Washington to ensure preferential treatment for generic drugs is maintained.

Source: Taipei Times April 03, 2026 17:16 UTC